ASPA hosts MEA Open House in Dubai to advance anti-counterfeiting collaboration
ASPA strengthens regional engagement in Middle East and Africa with participation from 17 companies
Author
Dr Reddy’s expands partnership with Sanofi to launch Beyfortus for RSV prevention in India
Dr Reddy’s to promote and distribute nirsevimab-based drug Beyfortus for RSV in newborns and infants
Morepen Laboratories receives CDSCO clearance for bioequivalence studies on Resmetirom
Morepen Laboratories advances Resmetirom development for NASH treatment following SEC approval
DP World achieves 65% renewable energy use in 2024, paving way for sustainable healthcare logistics
DP World’s latest sustainability report highlights its investment in green infrastructure and sustainable finance, supporting…
Zydus Lifesciences to Acquire 85.6% of Amplitude Surgical, block acquisition expected by Q3 2025
Zydus signs share purchase agreement to acquire majority stake in Amplitude Surgical, subject to regulatory approval and closing…
Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL
European Medicines Agency’s CHMP recommends approval of Biocon Biologics' denosumab biosimilars for bone health indications
Sun Pharma must immediately declare a voluntary recall of Levipil 500
Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…
ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…
Building a pharma-ready logistics network: The need for compliance, speed, and scalability
In the article, Nitesh Agarwal, President of CJ Darcl Logistics, outlines the critical infrastructure, regulatory, and…
Morepen Laboratories expands its domestic portfolio
The company strengthens its finished dosages business with new products across cardiology, hepatology, nutrition, and…